InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Read Simon. Officer active across 1 company, notably Dianthus Therapeutics, Inc. /DE/. Aggregated, 9 disclosures have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €545k. Activity tracked since 10 August 2026. The latest transaction was filed on 19 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Read Simon is a Director at Dianthus Therapeutics, Inc. /DE/ (XNAS). He has 7 filings in total, and across the 7 sampled filings dated 2026-08-11, the sell amount totals EUR 263252, with the modal transaction nature listed as Cession.